The Effect of Electromagnetic Field Treatment on Recovery from Ischemic Stroke in a Rat Stroke Model: Clinical, Imaging, and Pathological Findings.
Y Segal, L Segal, T Blumenfeld-Katzir...
https://pubmed.ncbi.nlm.nih.gov/26949561/Actively Recruiting
Led by Burke Rehabilitation Hospital · Updated on 2025-08-12
25
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating the Q Therapeutic BQ 3.0 System for individuals who have experienced a chronic stroke to see if it can improve upper limb function. This single-arm, open-label trial focuses on safety, feasibility, and effectiveness by using validated clinical assessments. The study also looks at other aspects like overall disability, quality of life, and safety outcomes in people with stroke lasting from 6 months to 5 years. The treatment involves 60 sessions over 12 weeks, with five sessions each week. Each session lasts up to 60 minutes and includes 40 minutes of active stimulation from the BQ 3.0 device combined with seated upper extremity exercises. After device use, participants perform 10 minutes of standing balance and lower extremity strengthening exercises without stimulation. The frequency and intensity of the electromagnetic fields range from 1 to 100 Hz and 0.1 to 1.0 Gauss, respectively, alongside a standardized physical and occupational therapy regimen. Participants will undergo a series of clinical assessments before and after completing the treatment sessions, including the Fugl-Meyer Assessment for upper extremity function and other measures like the Box and Block Test and stroke impact scales. These assessments will be conducted at baseline, 3 months, 5 months, and 6 months to evaluate changes in function, mood, balance, and quality of life. The total study duration includes the 12-week intervention period and follow-up assessments to monitor long-term effects.
CONDITIONS
Q Therapeutic System for Chronic Stroke Recovery
J
Josette Hartnett, MPH
A
Andrew Abdou, DO
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Burke Rehabilitation Hospital
Lead Sponsor
BrainQ Technologies Ltd.
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Q Therapeutic System (BQ 3.0) | Usual upper extremity rehabilitation |
|---|---|---|
| What it is | A medical device delivering non‑invasive, frequency‑tuned low‑intensity electromagnetic field therapy (BQ 3.0) to stimulate neural networks in adults with chronic upper limb impairment after stroke | The standard approach involves skilled physical and occupational therapy focusing on repetitive, task‑specific upper limb training to support motor recovery after stroke |
| Role in the trial | All participants received the investigational device as the sole active intervention | Not part of the trial protocol; represents external usual care |
| Primary use | Evaluated to reduce disability and promote neurorecovery in chronic stroke patients with upper extremity motor impairment | Used to improve upper limb function through repetitive therapy and task‑oriented exercises |
| How it is given or performed | Delivered via a wearable device that applies low‑frequency electromagnetic fields (1‑100 Hz, 0.1‑1.0 G) non‑invasively during treatment sessions | Provided by therapists through structured, repetitive exercises focused on upper limb movements |
| Evidence status | Preliminary evidence from pilot trials suggests potential benefit in upper limb motor recovery but remains experimental | Supported by clinical guidelines and systematic evidence as the current standard to promote motor recovery |
| Important risks | Not yet established; safety data are limited | Risks are generally known (for example fatigue or strain) and managed in clinical care |
| Important limitations | Evidence is limited to single‑group and small pilot trials; long‑term benefits and generalizability remain unproven | Effectiveness can vary based on therapy intensity, access to services, and adherence |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants receive active stimulation with the Q Therapeutic System paired with physical and occupational therapy exercises to improve upper extremity function after chronic stroke.
5 sessions per week for a total of up to 60 sessions
Duration - Up to 3 months after treatment
Participants undergo clinical assessments to evaluate recovery progress and safety after completing treatment.
Assessments at 3, 5, and 6 months post-baseline
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Y Segal, L Segal, T Blumenfeld-Katzir...
https://pubmed.ncbi.nlm.nih.gov/26949561/Batsheva Weisinger, Dharam P Pandey, Jeffrey L Saver...
https://pubmed.ncbi.nlm.nih.gov/36452175/Jeffrey L Saver, Pamela W Duncan, Joel Stein...
https://pubmed.ncbi.nlm.nih.gov/37213907/Naohiko Okabe, Mary Hovanesyan, Srbui Azarapetian...
https://pubmed.ncbi.nlm.nih.gov/37962771/Burke Rehabilitation Hospital
Lead Sponsor
BrainQ Technologies Ltd.
Collaborating Sponsor